Clinical investigation of medicinal products for the treatment of acute heart failure

Current effective version

PDF iconRevision 1 - Adopted guideline

Reference numberCPMP/EWP/2986/03 Rev.1
Published10/06/2015
Effective from01/12/2015
KeywordsAcute heart failure, acute decompensated heart failure, acute heart failure syndromes, chronic heart failure, dyspnoea, B-type natriuretic peptide (BNP)
DescriptionThis document provides guidance on the main regulatory requirements for the development of a medicinal product for the treatment of acute heart failure in adults. It focueses mainly on pharmacological intervention of left ventricular dysfunction with or without concomitant right ventricular dysfunction.


Document history

Revision 1

Current version

PDF iconAdopted guideline

 

PDF iconDraft guideline

 

PDF iconConcept paper

In operation: 01/12/2015–present

 

Published: 15/10/2012

 

Published: 04/06/2010

First version PDF iconAdopted guideline In operation: 01/01/2005–30/11/2015


Related content


How useful was this page?

Add your rating